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Abstract. In Multi-Criteria Decision Analysis-based decision support for person-
centred care, the person’s quantitative preferences (as criterion weightings) are 
combined with quantified evidence and expert assessments (as option performance 
ratings on all criteria) to produce a personalised quantified opinion (as a set of 
expected value option scores). In our current decision support tools, we use the best 
available (central point) estimates for option performance ratings. The uncertainty 
surrounding the performance rating estimates, routinely reported by researchers as 
intervals around the means, are ignored. While defensible, this paper responds to 
questioning of this disregard. Apart from the inappropriate ‘inverse variance’ 
method, we find no attempt to integrate parameter uncertainty into decision 
analyses, simply an emphasis on reporting it fully, leaving decision makers 
unsupported in the burden of dealing with the separated outputs – e.g. Means and 
Credible Intervals. The paper suggests that uncertainty can be brought within Multi-
Criteria Decision Analysis-based decision support by treating the means and 
uncertainties of all outcomes and process considerations as separate criteria, having 
them traded-off in an individually preference-sensitive manner at the point of 
decision. An empirical proof of method via an online example on bone health 
medications is provided, involving six options, two considerations and four criteria. 
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Introduction 
 
Uncertainty is the normal situation in decision making, in fact without it decision 
making - and therefore decision support - will often be unnecessary. How uncertainty - 
or rather uncertainties - should be dealt with varies with the paradigm within which the 
decision process, and hence decision support for it, is conceptualised. In the dominant 
paradigm in healthcare, researchers establish the expected average outcomes, along 
with the uncertainties, and hand over the burden of dealing with the separated outputs - 
e.g. Means and Credible Intervals (CIs) - to the decision maker. Considerable effort is 
rightly put into improving the estimates of uncertainty as well as the mean [1]. 
However, whether individual or group, the decision maker is expected to make the 
necessary trade-off between them as part of the final deliberative ‘making up of their 
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 mind’. There is no attempt to synthesise, transparently and systematically, the joint 
means and uncertainties of the performance ratings for all options on all criteria.  
 
In this paper we assume structural uncertainty has been dealt with appropriately and 
that stochastic uncertainty is simply the norm. We are therefore concerned here with 
the remaining parameter uncertainty (hereafter ‘uncertainty’). The estimates for the 
effects/outcomes (e.g. on life expectancy, quality of life) of an intervention (e.g. 
medication, surgery, lifestyle change) are almost always uncertain. Our focus is on the 
situation in which the best estimate of the mean value of a parameter for an individual 
person is available, accompanied by the best estimate of the uncertainty surrounding it.  
 
We note the much wider and open debate about how uncertainty is dealt with in 
decision making, and on whether and how decision makers should respect descriptive 
findings about this [2]. In confining ourselves to the specific and narrow issue above 
we are explicitly coming from a decision making, analysing, and supporting 
perspective which mandates a Bayesian position [3]. Here probabilities, which by 
definition relate to the future, or unknown present, are ontologically subjective, even if 
they are epistemologically based on 'objective' past frequencies. (We hence always 
refer to Credible rather than Confidence Intervals.) 
 
Method 
 
We take the view that computerised interactive decision support based on value-based, 
compensatory Multi-Criteria Decision Analysis (MCDA) is the best way to deliver 
preference-sensitive person-centred care that meets both ethical and legal requirements 
[4]. This involves the person’s quantitative preferences for outcomes and process 
considerations (as criterion weightings) being combined with quantified evidence and 
expert assessments (of the option performance Ratings on all criteria) to produce a 
personalised preliminary opinion (as a set of expected value option scores) on what is 
best for this individual. Currently we use the Best central point Estimates Available 
Now – the ‘mean BEANs’ – as the option performance Ratings inputs and regard this 
as a defensible position, in line with the orthodox position for many health economists. 
However, one option might have a higher mean Score, but a wider CI, than another. It 
is therefore often suggested that the decision maker would benefit from knowing these 
CIs, because they may prefer the latter option because of ‘uncertainty aversion’. We 
should therefore display the CI for each option Score. 
 
We acknowledge the argument for doing so, but would not want to supply the 
decision maker with this additional CI information as such, alongside and separate 
from the mean. In our person-centred decision support tools (PDSTs) we are 
committed to producing a comprehensive preference-sensitive index Score - one 
number - for each option. The required criterion-specific mean-uncertainty preference 
trade-offs are to be those of the decision maker, but they are not to be left to tackle this 
task unsupported outside the tool. The Scores produced by the tool are to incorporate 
the mean-uncertainty trade-offs elicited from the decision maker within the tool. They 
can disregard uncertainty, on normative or any ground, simply by giving it zero weight. 
 
 An MCDA that propagates uncertainty through the analysis and leaves the output 
in the form of the means and variances of overall option scores may constitute current 
good practice in decision modelling [5], but it leaves the necessary value judgments to 
be made and processed in some non-analytical, intuitive, and/or deliberative way. That 
this is intentional is confirmed in the most relevant ISPOR Task Force report, where it 
is emphasised that uncertainty surrounding any central point estimate is to be 
‘responsibly reported’, not further processed inside the model [6]. The recent ISPOR 
Task Force report on MCDA also suggests uncertainty is something to be explored 
within the presentation of the model, but there is no suggestion that the decision 
maker’s trade-offs should be integrated within it [7]. 
Parameter uncertainty (e.g., uncertainty in the performance of alternatives) 
can be addressed using techniques such as probabilistic sensitivity analysis 
techniques… The results from MCDA should not be taken as the “final 
decision” but rather the MCDA model should be used to explore the 
uncertainty in the decision problem. The decision makers can be presented 
with results from analyses exploring different types of uncertainty (e.g., 
parameter uncertainty, structural uncertainty, and heterogeneity) to support 
decision making. [7] (p12). 
 
Personally, we question the assumptions made by mainstream decision modellers 
about a decision maker’s competence to accomplish the implicit trade-off task 
accountably without analytical support. However, whether or not this rejection is 
justified is irrelevant. Our aim is simply to investigate the possibility of generating a 
preference-sensitive opinion on the decision that includes explicit trade-offs of means 
and uncertainties, based on a transparent analysis.  
 
There is no place in PCDS for the most frequent way uncertainty adjustment is 
undertaken, inside or outside MCDA, by the ‘inverse variance’ procedure. This ignores 
the fact that the individual decision-maker’s trade-offs may vary by criterion (e.g. life 
expectancy vs. adverse effects) and by option (e.g. medication vs. surgery). Sensitivity 
analysis, whether deterministic or probabilistic, does not meet the PCDS requirement, 
merely re-presenting the problem for the decision maker in a different form. Because of 
their complexity, Bayesian Networks, Dempster-Shafer theory, Fuzzy Set Theory and 
Grey [8] theory all fail most tests of feasibility and practicality in the context of PCDS. 
More important for the present argument, none is relevant to the situation in which the 
results of research comes in the form of means and uncertainties. 
 
Result: Preference-sensitive uncertainty adjustment 
 
In our experience, committees, such as NICE Technology Appraisal ones, look at the 
CIs by ‘eyeballing’ them. They are not explicit or systematically processed. Decision 
makers may not be Expected Value (EV) maximisers, but they will still need some 
procedure for integrating the means and CIs produced by researchers. In our view that 
should be a systematic and transparent algorithm.  
 
The contemplated answer, advanced for debate, is to treat the mean and 
uncertainty of a criterion as separate attributes. This suggestion is not new, except in 
 PCDS. Durbach and Stewart introduce it in their comprehensive review (9). ‘Given the 
aim of taking external uncertainty about outcomes on an attribute into account, one 
possible approach is to use some measure of the consequences of this uncertainty as an 
attribute in its own right.’ (p.6) 
 
To follow three illustrative examples fully and interactively, the reader is invited to go 
to https://ale.rsyd.dk, enter 1406 as survey ID. (Note that no data security is offered.) 
The examples are in the Annalisa implementation of MCDA, embedded in the survey 
program Elicia. In the example below, the data are from a Network Meta-Analysis on 
medications to reduce fracture risk [10]. We use the absolute CI as our uncertainty 
indicator and with positively-oriented criteria the indicator is actually (1- absolute CI).  
 
 
Figure 1: Screen capture showing uncertainty-adjusted MCDA 
 
The decision maker has their importance weights for mean and uncertainty elicited 
for each criterion separately, so the trade-offs are criterion-specific, permitting that for 
Vertebral fracture to be different from that for Non-vertebral fracture. In our tools, this 
elicitation is done on a 0-10 slider ratio scale, with the responses being normalized to 
add to 100%. We do not see swing weighting, pairwise comparisons, or discrete choice 
experiments [11] as remotely practical in a direct-to-citizen, apomediative [12-13], 
approach to clinical decision support. Moreover, the Visual Analog Scale approach is 
defensible on grounds other than its practicality [14].  The decision maker has the 
ability to vary the criterion weightings in the interactive display. 
 
 The result is a personalised evaluation of each option sensitive to the preferences 
of the decision owner – the person/patient – as captured in their criterion Weightings. 
These evaluations can be a valuable input into the subsequent decision deliberation. 
 
Conclusion 
 
In one view the setting up of mean and uncertainty as separate criteria involves double 
counting, in that the calculation of the Expected Value has already ‘synthesised’ the 
uncertainty in the distribution. In the alternative view, the calculation of the mean, has 
left the uncertainty surrounding it to be addressed by the decision maker, alongside the 
mean. Their relative weighting of the two can be entered into a new EV calculation. In 
this view the trade-off between mean and uncertainty for each criterion is a preference-
based value judgment and the opportunity to make it should be offered to all decision 
makers at or near the point of decision. The aim here is limited to providing proof of 
method for the latter possibility, as a basis for the debate and research we hope ensue. 
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